Simon Barry J.'s Form 4 filing
ImmunityBio, Inc. (IBRX) · filed Feb 24, 2026
- Accession no.
- 0001647994-26-000004
- Filed
- Feb 24, 2026
- Trade date
- Feb 20-23, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.78M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Simon Barry J.CIK 0001647994 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 20, 2026 | Common Stock | SSaleDisposed | −10,000 | $9.25 | −$92,500 | 3,081,604 | Direct | |
| Feb 22, 2026 | Common Stock | MOption exerciseAcquired | +15,243 | $0.00 | $0 | 3,096,847 | Direct | |
| Feb 22, 2026 | Common Stock | FTax withholdingDisposed | −6,026 | $8.70 | −$52,426.2 | 3,090,821 | Direct | |
| Feb 23, 2026 | Common Stock | SSaleDisposed | −165,000 | $10.25 | −$1,691,250 | 2,925,821 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 22, 2026 | Common Stock | MOption exerciseDisposed | −15,243 | $0.00 | $0 | 15,245 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.